MYRF haploinsufficiency causes 46,XY and 46,XX disorders of sex development: bioinformatics consideration.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
15 07 2019
Historique:
received: 11 01 2019
revised: 06 03 2019
accepted: 21 03 2019
pubmed: 16 4 2019
medline: 13 3 2020
entrez: 16 4 2019
Statut: ppublish

Résumé

Disorders of sex development (DSDs) are defined as congenital conditions in which chromosomal, gonadal or anatomical sex is atypical. In many DSD cases, genetic causes remain to be elucidated. Here, we performed a case-control exome sequencing study comparing gene-based burdens of rare damaging variants between 26 DSD cases and 2625 controls. We found exome-wide significant enrichment of rare heterozygous truncating variants in the MYRF gene encoding myelin regulatory factor, a transcription factor essential for oligodendrocyte development. All three variants occurred de novo. We identified an additional 46,XY DSD case of a de novo damaging missense variant in an independent cohort. The clinical symptoms included hypoplasia of Müllerian derivatives and ovaries in 46,XX DSD patients, defective development of Sertoli and Leydig cells in 46,XY DSD patients and congenital diaphragmatic hernia in one 46,XY DSD patient. As all of these cells and tissues are or partly consist of coelomic epithelium (CE)-derived cells (CEDC) and CEDC developed from CE via proliferaiton and migration, MYRF might be related to these processes. Consistent with this hypothesis, single-cell RNA sequencing of foetal gonads revealed high expression of MYRF in CE and CEDC. Reanalysis of public chromatin immunoprecipitation sequencing data for rat Myrf showed that genes regulating proliferation and migration were enriched among putative target genes of Myrf. These results suggested that MYRF is a novel causative gene of 46,XY and 46,XX DSD and MYRF is a transcription factor regulating CD and/or CEDC proliferation and migration, which is essential for development of multiple organs.

Identifiants

pubmed: 30985895
pii: 5424416
doi: 10.1093/hmg/ddz066
doi:

Substances chimiques

Membrane Proteins 0
Myrf protein, human 0
Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2319-2329

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Kohei Hamanaka (K)

Department of Human Genetics.

Atsushi Takata (A)

Department of Human Genetics.

Yuri Uchiyama (Y)

Department of Human Genetics.
Department of Oncology.

Satoko Miyatake (S)

Department of Human Genetics.
Clinical Genetics Department, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.

Noriko Miyake (N)

Department of Human Genetics.

Satomi Mitsuhashi (S)

Department of Human Genetics.

Kazuhiro Iwama (K)

Department of Human Genetics.

Atsushi Fujita (A)

Department of Human Genetics.

Eri Imagawa (E)

Department of Human Genetics.

Ahmed N Alkanaq (AN)

Department of Human Genetics.

Eriko Koshimizu (E)

Department of Human Genetics.

Yoshiki Azuma (Y)

Department of Human Genetics.
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Mitsuko Nakashima (M)

Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

Takeshi Mizuguchi (T)

Department of Human Genetics.

Hirotomo Saitsu (H)

Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

Yuka Wada (Y)

Department of Neonatology, National Center for Child Health and Development, Setagaya, Tokyo, Japan.

Sawako Minami (S)

Deparment of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, Wakayama, Japan.

Yuko Katoh-Fukui (Y)

Department of Molecular Endocrinology, National Center for Child Health and Development, Setagaya, Tokyo, Japan.

Yohei Masunaga (Y)

Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

Maki Fukami (M)

Department of Molecular Endocrinology, National Center for Child Health and Development, Setagaya, Tokyo, Japan.

Tomonobu Hasegawa (T)

Department of Pediatrics, Keio University School of Medicine, Shinjuku, Tokyo, Japan.

Tsutomu Ogata (T)

Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

Naomichi Matsumoto (N)

Department of Human Genetics.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH